ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $3,000 | +200.0% | 400 | +100.0% | 0.00% | – |
| Q4 2013 | $1,000 | -75.0% | 200 | 0.0% | 0.00% | – |
| Q3 2013 | $4,000 | -80.0% | 200 | -83.3% | 0.00% | -100.0% |
| Q2 2013 | $20,000 | -9.1% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q1 2013 | $22,000 | -4.3% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q4 2012 | $23,000 | -20.7% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q3 2012 | $29,000 | +45.0% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q2 2012 | $20,000 | +5.3% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q1 2012 | $19,000 | +35.7% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q4 2011 | $14,000 | +55.6% | 1,200 | +20.0% | 0.00% | – |
| Q3 2011 | $9,000 | -66.7% | 1,000 | -58.8% | 0.00% | -100.0% |
| Q2 2011 | $27,000 | +50.0% | 2,425 | 0.0% | 0.00% | 0.0% |
| Q1 2011 | $18,000 | +260.0% | 2,425 | +142.5% | 0.00% | – |
| Q4 2010 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2010 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |